Vimarsana
Biggest News Aggregation in the World

Page 3 - Linical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Evolution Today - Breaking & Trending Today

Women in Science: Dr Laura Trotta – 'I joined CluePoints because of the research but also the mindset' - Vimarsana News

Women in Science: Dr Laura Trotta – 'I joined CluePoints because of the research but also the mindset'

Dr Laura Trotta joined CluePoints in 2015 and moved into her current role as vice president of research in January 2022, where she leads a team of research scientists responsible for developing new statistical and machine learning algorithms to assess the quality of clinical trial data.

Progress: Molecure's 2023 milestones and what lies ahead - Vimarsana News

Progress: Molecure's 2023 milestones and what lies ahead

Molecure S.A., a leading biotechnology company focused on drug discovery and development, has unveiled its annual report for 2023 at the start of the new financial year.

HUTCHMED & Innovent Secure NDA for Cancer Combo in China - Vimarsana News

HUTCHMED & Innovent Secure NDA for Cancer Combo in China

In an important announcement today (April 2), HUTCHMED and Innovent jointly revealed the acceptance of their New Drug Application (NDA) in China for the combination of Fruquintinib with Sintilimab.

One2Treat: can it transfrom clinical research? - Vimarsana News

One2Treat: can it transfrom clinical research?

Today (March 26) One2Treat, a progressive startup specializing in digital health solutions, has launched a forward-thinking approach aimed at tackling key challenges in the biopharma industry.

Radboud University - finding the best way to diagnose rare diseases - Vimarsana News

Radboud University - finding the best way to diagnose rare diseases

Being able to identify rare diseases is challenging especially since more than 80% of them have genetic origins.